Skin News and Research

RSS

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Physio-Control, Inc., a global leader in emergency medical solutions and wholly‐owned subsidiary of Medtronic, Inc.,, today announced commercial availability of the ReadyLink™ 12-Lead ECG device, a new, U.S. Food and Drug Administration (FDA) 510(k)-cleared solution designed to improve care for heart attack patients and expand regional STEMI systems.

From Medtronic 24 Aug 2011

Melanin also protects from ionizing radiation

Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.

24 Aug 2011

Toddlers sensitive to house dust mites at higher risk of developing asthma

Wheezy toddlers who have a sensitivity to house dust mites are more at risk of developing asthma by the age of 12, a University of Melbourne led study has shown.

24 Aug 2011

New stem cell lines help study genetic, biological underpinnings of bipolar disorder

New stem cell lines developed from the skin of adults living with bipolar disorder are providing researchers at the University of Michigan Health System an unprecedented opportunity to delve into the genetic and biological underpinnings of the devastating mood disorder.

24 Aug 2011

Scientists generate stem cells from one of the most rapidly progressing forms of Parkinson's

Scientists have for the first time generated stem cells from one of the most rapidly progressing forms of Parkinson's disease.

24 Aug 2011

Bullet proof skin from human cells and spider silk

Dutch artist Jalila Essaidi, along with Utah State researcher Randy Lewis have made a swatch of nearly bulletproof skin made from spider silk and human skin cells. The project called “2.6g 329m/s” takes its name from the maximum weight and velocity a Type 1 bulletproof vest can withstand from a .22 calibre Long Rifle bullet.

23 Aug 2011

Dogs ‘sniff’ out early lung cancer accurately

According to a new study in the European Respiratory Journal dogs are better at sniffing out the early markers of lung cancer than the latest medical technologies at our disposal.

23 Aug 2011

Roche Canada grants Vasculitis and Scleroderma Fellowship

Roche Canada announced today its support of a Vasculitis and Scleroderma Fellowship through the Division of Rheumatology at the University of British Columbia (UBC). Dr. Ada Man, a recent graduate of the UBC rheumatology residency program, is the recipient of the one-year Fellowship.

23 Aug 2011

Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

VeraLight Inc., the first company to develop an optical skin measurement for noninvasive diabetes screening, and Pear Healthcare Solutions Inc., a leading provider of in-pharmacy health screening and education services, today announced an agreement for the distribution of the SCOUT DS device in pharmacies across Canada.

23 Aug 2011

Stem cells of oral mucosa stay young, says Tel Aviv University researcher

While highly potent embryonic stem cells are often the subject of ethical and safety controversy, adult-derived stem cells have other problems. As we age, our stem cells are less pliant and less able to transform into the stem cells that science needs to find breakthrough treatments for disease.

23 Aug 2011

Scientists identify brain-circuit defect that triggers absence seizures

Researchers at the Stanford University School of Medicine have identified a brain-circuit defect that triggers absence seizures, the most common form of childhood epilepsy.

23 Aug 2011

Nurse safety measures around highly toxic drugs needed

Nearly 17 percent of nurses who work in outpatient chemotherapy infusion centers reported being exposed on their skin or eyes to the toxic drugs they deliver, according to a new study from the University of Michigan Comprehensive Cancer Center.

22 Aug 2011

NIH bias against African-Americans confirmed

Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.

22 Aug 2011

Marital bliss triples long-term survival after coronary bypass surgery

Giving your heart to a supportive spouse turns out to be an excellent way to stay alive, according to new research from the University of Rochester. Happily wedded people who undergo coronary bypass surgery are more than three times as likely to be alive 15 years later as their unmarried counterparts, reports a study published online August 22 in Health Psychology, a publication of the American Psychological Association.

22 Aug 2011

Pulse oximetry can identify newborns with congenital heart disease

About 1 in every 120 babies are born with congenital heart disease (CHD), of which about 25 percent is critical, requiring special care early in life. CHD is responsible for more deaths in the first year of life than any other birth defect, but often outcomes can be improved with early detection.

22 Aug 2011

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

The corpus delicti is a plain flacon from among the possessions of Pharaoh Hatshepsut, who lived around 1450 B.C., which is on exhibit in the permanent collection of the Egyptian Museum of the University of Bonn. For three and a half millennia, the vessel may have held a deadly secret. This is what the Head of the collection, Michael H-veler-M-ller and Dr. Helmut Wiedenfeld from the university's Pharmacology Institute just discovered.

20 Aug 2011

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.

20 Aug 2011

Powerful X-rays help develop new drug treatment for malignant melanoma

Powerful X-ray technology developed at the U.S. Department of Energy's (DOE's) national laboratories is revealing new insights into diseases ranging from Alzheimer's to the swine flu, and, most recently, enabled the discovery of a groundbreaking new drug treatment for malignant melanoma, the deadliest form of skin cancer.

19 Aug 2011

Femtosecond-laser ablation of Xenopus melanocytes for studies of cell migration, wound repair

Using an ultrafast femtosecond laser, researchers at Tufts University in Medford, Mass., were able to label, draw patterns on, and remove individual melanocytes cells from a species of frog tadpole (Xenopus) without damaging surrounding cells and tissues.

19 Aug 2011

Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells

By employing optogenetics, a new field that uses genetically altered cells to respond to light, and a tandem unit cell (TCU) strategy, researchers at Stony Brook University have demonstrated a way to control cell excitation and contraction in cardiac muscle cells, the details of which are published in the early online edition of Circulation: Arrhythmia & Electrophysiology: "Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery."

19 Aug 2011

Skin News and Research

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Melanin also protects from ionizing radiation

Toddlers sensitive to house dust mites at higher risk of developing asthma

New stem cell lines help study genetic, biological underpinnings of bipolar disorder

Scientists generate stem cells from one of the most rapidly progressing forms of Parkinson's

Bullet proof skin from human cells and spider silk

Dogs ‘sniff’ out early lung cancer accurately

Roche Canada grants Vasculitis and Scleroderma Fellowship

Pear, VeraLight partner to distribute SCOUT DS device in pharmacies across Canada

Stem cells of oral mucosa stay young, says Tel Aviv University researcher

Scientists identify brain-circuit defect that triggers absence seizures

Nurse safety measures around highly toxic drugs needed

NIH bias against African-Americans confirmed

Marital bliss triples long-term survival after coronary bypass surgery

Pulse oximetry can identify newborns with congenital heart disease

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

Powerful X-rays help develop new drug treatment for malignant melanoma

Femtosecond-laser ablation of Xenopus melanocytes for studies of cell migration, wound repair

Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News